MGMT and glioblastoma: Since expression, and thus activity, of the related protein is prevented in some GBM cells by methylation of the promoter of this gene, GBM cells displaying hypo- or non-methylated MGMT gene express more MGMT protein, thus being less sensitive to TMZ, causing an intrinsic or acquired resistance to this drug.